According to BELLUS Health's latest financial reports the company has $0.31 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.33 B | 35.47% |
2021-12-31 | $0.24 B | 153.21% |
2020-12-31 | $98.26 M | 43.42% |
2019-12-31 | $68.51 M | 159.91% |
2018-12-31 | $26.35 M | 74.57% |
2017-12-31 | $15.09 M | 298.96% |
2016-12-31 | $3.78 M | -24.91% |
2015-12-31 | $5.03 M | -44.83% |
2014-12-31 | $9.13 M | -32.31% |
2013-12-31 | $13.49 M | -28.1% |
2012-12-31 | $18.77 M | 283.26% |
2011-12-31 | $4.89 M | -52.26% |
2010-12-31 | $10.25 M | -19.4% |
2009-12-31 | $12.72 M | 46.08% |
2008-12-31 | $8.71 M | -85.11% |
2007-12-31 | $58.51 M | 39.76% |
2006-12-31 | $41.86 M | -20.31% |
2005-12-31 | $52.54 M | 160.06% |
2004-12-31 | $20.2 M | -43.4% |
2003-12-31 | $35.69 M | |
2003-06-30 | $8.87 M | -23.71% |
2002-06-30 | $11.63 M | -33.29% |
2001-06-30 | $17.43 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -33.48% | ๐บ๐ธ USA |